As responsible investors, Candriam assesses the positioning of investee companies across several categories of factors, health and wellness among them.
The incidence and cost of obesity and other metabolic syndrome conditions have grown at a startling rate over the last fifty years. These now impact people around the world, including emerging markets, and of all ages, including children.
The cost to society is reaching an unbearable level – estimates suggest a full 1% to 2% of world GDP in health costs due to bad diets. The cost is both large, and at the moment, largely hidden.